insights_auto
Why is ORX down 64,38%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,50 SEK
arrow_downward
-64,38%(-2,71) 1D
3-ноя., 17:29:38 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
3,92 SEK
High
3,92 SEK
Low
1,50 SEK
Mkt. cap
52,56 млн
Avg. vol.
148,54 миң
Volume
3,89 млн
P/E ratio
0,07
52-wk high
36,00 SEK
52-wk low
1,50 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
3,92 SEK
High
3,92 SEK
Low
1,50 SEK
Mkt. cap
52,56 млн
Avg. vol.
148,54 миң
Volume
3,89 млн
P/E ratio
0,07
52-wk high
36,00 SEK
52-wk low
1,50 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Local 3 News
·
1 саат мурун
RAW: NYSE: CLOSING BELL TUESDAY
FinancialContent
·
45 мүнөт мурун
QuidelOrtho (NASDAQ:QDEL) reports sales below analyst estimates in Q3 2026 earnings, stock drops 10.6%
MoneyLion
·
2 мүнөт мурун
S&P 500 Growth Is Slowing: What Retirees Should Know
Barchart.com
·
56 мүнөт мурун
Booking (NASDAQ:BKNG) reports sales below analyst estimates in Q3 2026 earnings
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteorexo.com